Telix Pharmaceuticals cleared a level that had been marking its recent high, pushing through after a shallow pullback held above support and buyers stepped back in with force. The move came on volume roughly triple the recent average, a strong sign that real participation is behind the breakout rather than a handful of thin trades. Trend strength and momentum both read constructively here, supporting the case for continuation while shares hold above the breakout zone. The stop reference sits back under the area that had been defended during the pullback, keeping the risk defined close to current levels.

Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.